Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient’s informed consent Age of patient- 55-75years Patients undergoing Total Knee Replacement Surgery ASA grade I,II
Exclusion criteria
Exclusion criteria: Patient’s refusal Any bleeding disorder or coagulopathies ASA grade III,IV Allergy/contraindication to any drugs used in study Chronic opioid user Any neurologic deficit Failed neuraxial anaesthesia Infection/inflammation at site of injection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the analgesic efficacy of intermittent bolus versus continuous infusion of Ropivacaine in adductor canal block using Numerical Rating scaleTimepoint: Pain shall be assessed at 0,4,8,12,24 hours and 0.25% Ropivacaine 20ml shall be given in adductor canal if Numerical Rating Scale is more than 3 at any given time. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the motor block between the two groups using the Modified Bromage scale Timepoint: The patients will be assessed for motor blockade every 6 hours interval for 24 hours postoperatively by the Modified Bromage Scale.;To compare the total amount of Ropivacaine consumed between the study groupsTimepoint: Amount of Ropivacaine consumed during the observation period of 24hours is calculated in milligrams | — |
Countries
India
Contacts
Tata Motors Hospital